Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
66.94
USD
-0.04 (-0.06%)
Official Closing Price
Updated: 7:59 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Gilead Sciences
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
3 Reasons This Hot Stock May Not Survive 2021
January 24, 2021
This promising cancer fighter might sell out this year to cash in on its potential.
Tags
SURF
BMY
GILD
From
Motley Fool
3 Blockbuster Drug Launches to Watch This Year
January 24, 2021
These are the recently approved treatments biotech investors want to keep their eyes on in 2021.
Tags
PFE
RHHBY
BPMC
From
Motley Fool
Better Buy: Gilead Sciences vs. Pfizer
January 23, 2021
One has a top COVID-19 treatment, the other has a top COVID-19 vaccine. Which stock will come out on top.
Tags
PFE
GILD
Market News
From
Motley Fool
Gilead Sciences shares rise as Morgan Stanley upgrades its price target to $83
January 22, 2021
Tags
features
Market analysis
Stocks & shares
From
Invezz
Where Will Sorrento Therapeutics Be in 1 Year?
January 22, 2021
Can this biotech finally demonstrate progress in its COVID-19 pipeline before it's too late?
Tags
Market News
SRNE
GILD
From
Motley Fool
Pfizer, GSK-Backed ViiV First To Get FDA Approval For HIV Shots: What You Need To Know
January 22, 2021
In a first, a monthly injectable HIV drug made by a GlaxoSmithKline plc (NYSE: GSK)- and Pfizer Inc (NYSE: PFE)-owned company has ...
Tags
HIV treatment
PFE
Benzinga
From
Benzinga
Gilead Sciences to Release Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 4, 2021
January 21, 2021
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2020 financial results will be released on Thursday, February 4, after the market closes. At 4:30 p.m. Eastern...
From
Business Wire News Releases
Biden Stocks: 16 Stocks to Watch for a Defense Production Act Boost
January 21, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Biden stocks like APT stock, KODK stock, MMM stock and CAH stock are all...
Tags
HON
OMI
PFE
From
InvestorPlace
GILD March 5th Options Begin Trading
January 21, 2021
Investors in Gilead Sciences Inc (GILD) saw new options begin trading today, for the March 5th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GILD options chain...
Tags
Stocks
From
Market News Video
3 Top Stocks for Retirees
January 21, 2021
Investors can buy and hold these stocks without losing sleep at night.
Tags
Market News
ZM
MA
From
Motley Fool
My Best SaaS Stock for 2021
January 20, 2021
Veeva Systems could double its annual revenue over the next four years.
Tags
MRNA
PFE
Market News
From
Motley Fool
2 High-Yield Dividend Stocks to Buy Now
January 20, 2021
Both stocks provide payouts that put the average stock on the S&P 500 to shame.
Tags
GILD
PFE
MRNA
From
Motley Fool
Biopharma Leads Healthcare Portfolio 2020-2021
January 19, 2021
Clearly, biopharma stocks, both large and small, led the way to outperformance within healthcare. But Q4 2020 was very speculative, so we expect that the momentum will ebb in 2021 in a shift to...
Tags
Mutual Funds
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
Notable Tuesday Option Activity: GM, GILD, TWTR
January 19, 2021
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in General Motors Co (GM), where a total of 445,846 contracts have traded so far, representing...
Tags
Stocks
From
Market News Video
Gilead's 'Pivotal Year' — Why An Analyst Is Bullish Enough To Upgrade Shares
January 19, 2021
Gilead stock rocketed Tuesday after an analyst suggested 2021 would be a pivotal year as the biotech advances key medicines for HIV and breast cancer.
From
Investor's Business Daily
Why Gilead Sciences Stock Is Jumping Today
January 19, 2021
A Wall Street analyst upgraded the biotech stock.
Tags
Market News
MRK
GILD
From
Motley Fool
The Gilead, Galapagos Pipeline Opportunities That Are Turning Morgan Stanley Bullish
January 19, 2021
Gilead Sciences, Inc. (NASDAQ: GILD) and its R&D partner Galapagos ADR Representing Ord Shs (NASDAQ: GLPG) received an upgrade each ...
Tags
Upgrades
Benzinga
GLPG
From
Benzinga
Nasdaq 100 Movers: PTON, GILD
January 19, 2021
In early trading on Tuesday, shares of Gilead Sciences topped the list of the day's best performing components of the Nasdaq 100 index, trading up 5.1%. Year to date, Gilead Sciences registers a 14.2%...
Tags
Stocks
From
Market News Video
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2021
January 19, 2021
Upgrades For Wells Fargo & Co (NYSE:WFC), Seaport Global upgraded the previous rating of Neutral to Buy. Wells Fargo ...
Tags
GGG
JBHT
QSR
From
Benzinga
Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research
January 19, 2021
Kite, a Gilead Company (Nasdaq: GILD), today announced that Francesco Marincola, MD, will join the company as Senior Vice President and Global Head of Cell Therapy Research, effective February 1. Dr....
From
Business Wire News Releases
3 Biotech Stocks To Watch This Week
January 18, 2021
Tags
Market News
From
Stockmarket.com
Gilead Stock 2021: Why The Biotech Stock Isn't Depending On Covid Drugs
January 15, 2021
Gilead Sciences isn't betting its 2021 on coronavirus treatment Veklury. But the biotech company still sees plenty of catalysts in oncology, virology and inflammation for Gilead stock.
From
Investor's Business Daily
IBB, AMGN, GILD, REGN: Large Inflows Detected at ETF
January 15, 2021
Symbols mentioned in this story: IBB, AMGN, GILD, REGN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
Is Novavax's Growth Story Over?
January 15, 2021
The next few weeks could be critical for the biotech's coronavirus vaccine prospects.
Tags
Market News
NVAX
PFE
From
Motley Fool
3 Top Biotech Picks for January
January 13, 2021
Buy these three biotech stocks before they take off.
Tags
Market News
PFE
AMGN
From
Motley Fool
Is Gilead Sciences a Good Coronavirus Stock to Buy?
January 13, 2021
The biotech made headlines last year as the first to market a coronavirus treatment. What's in store for it in 2021?
Tags
Market News
GILD
From
Motley Fool
1 Big Reason Trillium Therapeutics Stock's Hot Streak Will Continue in 2021
January 12, 2021
When it comes to countering a key trick that cancer plays on the human immune system, this biotech has no equal.
Tags
TRIL
GILD
Market News
From
Motley Fool
Why Vir Biotechnology Stock Vaulted Higher Today
January 12, 2021
The biotech announced updates about collaborations with two big partners.
Tags
GILD
VIR
GSK
From
Motley Fool
Beigene Surges Closer To Breakout On $2.2 Billion Deal With Novartis
January 12, 2021
Beigene stock jumped Tuesday on a cancer drug development deal with Novartis worth up to $2.2 billion, as Vir Biotechnology also announced a hepatitis B tie-up with Gilead Sciences.
From
Investor's Business Daily
Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic Hepatitis B Virus
January 12, 2021
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.